Universal screening for prenatal alcohol exposure: A progress report of a pilot study in the region of grey bruce, ontario

Therapeutic Drug Monitoring

Volumn 32, Issue 3, 2010, Pages 305-310

  Zelner, Irene ^a,b   Shor, Sarit ^a,b   Gareri, Joey ^a   Lynn, Hazel ^c   Roukema, Henry ^d   Lum, Lisa ^d   Eisinga, Kirsten ^d   Nulman, Irena ^a   Koren, Gideon ^a,b,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Grey Bruce Health Unit   (Canada)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Fatty acid ethyl esters; Fetal alcohol spectrum disorder; Follow up; Meconium; Neonatal screening

Indexed keywords

ALCOHOL; FATTY ACID ESTER;

ALCOHOL INTOXICATION; CANADA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FETAL ALCOHOL SYNDROME; HUMAN; INFANT; MALE; MASS FRAGMENTOGRAPHY; MECONIUM; NEWBORN; NEWBORN SCREENING; PILOT STUDY; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SOLID PHASE MICROEXTRACTION;

ALCOHOLISM; ESTERS; ETHANOL; FATTY ACIDS; FEMALE; FETAL ALCOHOL SYNDROME; FETUS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HOSPITAL UNITS; HUMANS; INFANT; INFANT, NEWBORN; LONDON; MASS SCREENING; MECONIUM; ONTARIO; PILOT PROJECTS; PREGNANCY; PRENATAL CARE; PROGRAM DEVELOPMENT;

EID: 77952958611     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181dca381     Document Type: Conference Paper

References (41)

1. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health. 2001;25:159-167.
2. Sampson PD, Streissguth AP, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997;56:317-326.
3. Abel EL, Sokol RJ. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend. 1987;19:51-70.
4. Lupton C, Burd L, Harwood R. Cost of fetal alcohol spectrum disorders. Am J Med Genet C Semin Med Genet. 2004;127C:42-50.
5. Stade B, Ali A, Bennett D, et al. The burden of prenatal exposure to alcohol: revised measurement of cost. Can J Clin Pharmacol. 2009;16: e91-e102.
6. Streissguth AP, Bookstein FL, Barr HM, et al. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25:228-238.
7. Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA. 2003;290:2996-2999.
8. Chudley AE, Conry J, Cook JL, et al. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005;172:S1-S21. (Pubitemid 40342084)
9. Littner Y, Bearer CF. Detection of alcohol consumption during pregnancy-current and future biomarkers. Neurosci Biobehav Rev. 2007;31:261-269.
10. Koren G, Hutson J, Gareri J. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther. 2008;83:631-634.
11. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J Chromatogr B Biomed Sci Appl. 1998;713:137-146.
12. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn drug testing. National Academy of Clinical Biochemistry. Clin Chem. 1997;43:235-242.
13. Best CA, Laposata M. Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front Biosci. 2003; 8:e202-e217.
14. Moore CM, Lewis D. Fatty acid ethyl esters in meconium: biomarkers for the detection of alcohol exposure in neonates. Clin Chim Acta. 2001;312: 235-237.
15. Bearer CF, Gould S, Emerson R, et al. Fetal alcohol syndrome and fatty acid ethyl esters. Pediatr Res. 1992;31:492-495.
16. Bearer CF, Lee S, Salvator AE, et al. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 1999; 23:487-493.
17. Klein J, Karaskov T, Korent G. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther Drug Monit. 1999;21:644-646.
18. Bearer CF, Jacobson JL, Jacobson SW, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003;143:463-469.
19. Bearer CF, Santiago LM, O'Riordan MA, et al. Fatty Acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr. 2005;146:824-830.
20. Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25:271-278.
21. Moore C, Jones J, Lewis D, et al. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem. 2003;49:133-136.
22. Brien JF, Chan D, Green CR, et al. Chronic prenatal ethanol exposure and increased concentration of fatty acid ethyl esters in meconium of term fetal Guinea pig. Ther Drug Monit. 2006;28:345-350.
23. Gareri J, Lynn H, Handley M, et al. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther Drug Monit. 2008;30:239-245.
24. Littner Y, Cudd TA, O'Riordan MA, et al. Elevated fatty acid ethyl esters in meconium of sheep fetuses exposed in utero to ethanol-a new animal model. Pediatr Res. 2008;63:164-168.
25. Chan D, Knie B, Boskovic R, et al. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. J Pharmacol Exp Ther. 2004; 310:75-82.
26. Derauf C, Lagasse LL, Smith LM, et al. Demographic and psycho-social characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant Development, Environment, and Lifestyle Study (IDEAL). Am J Drug Alcohol Abuse. 2007;33: 281-289.
27. Noland JS, Singer LT, Arendt RE, et al. Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana. Alcohol Clin Exp Res. 2003;27:647-656.
28. Peterson J, Kirchner HL, Xue W, et al. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J Pediatr. 2008;152:788-792.
29. Jacobson SW. Meconium fatty acid ethyl esters (FAEEs) as predictors of severity of fetal alcohol spectrum disorder. Alcohol Clin Exp Res. 2006; 30:S175.
30. Hutson J, Magri R, Suarez H, et al. High prevalence of prenatal exposure to alcohol and other drugs of abuse in Uruguay as determined by meconium analysis. Alcohol Clin Exp Res. 2007;31:A718.
31. Leonardson GR, Loudenburg R. Risk factors for alcohol use during pregnancy in a multistate area. Neurotoxicol Teratol. 2003;25:651-658.
32. Etchells E, Sharpe G, Walsh P, et al. Bioethics for clinicians: 1. Consent. CMAJ. 1996;155:177-180.
33. Flagler E, Baylis F, Rodgers S. Bioethics for clinicians: 12. Ethical dilemmas that arise in the care of pregnant women: rethinking 'maternal-fetal conflicts.' CMAJ. 1997;156:1729-1732.
34. Hermeren G Neonatal screening: ethical aspects. Acta Paediatr Suppl. 1999;88:99-103.
35. Ontario Ministry of Health and Long-Term Care. Healthy Babies Healthy Children Report Card. 6-1-2003. Available at: http://www.health.gov. on.ca/english/public/pub/ministry-reports/healthy-babies-report/hbabies- report.html. Accessed July 25, 2009.
36. Hutson JR, Aleksa K, Pragst F, et al. Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:8-12.
37. Goh YI, Hutson J, Roukema H, et al. Risk of fetal alcohol exposure among newborns in a high risk unit. Clin Pharmacol Ther. 2008;83:S75
38. Public Health Agency of Canada. HIV/AIDS Epi Updates. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2006.
39. Pragst F, Auwaerter V, Sporkert F, et al. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci Int. 2001;121:76-88.
40. Bertrand J. Interventions for children with fetal alcohol spectrum disorders (FASDs): overview of findings for five innovative research projects. Res Dev Disabil. 2009;30:986-1006.
41. Peadon E, Rhys-Jones B, Bower C, et al. Systematic review of interventions for children with fetal alcohol spectrum disorders. BMC Pediatr. 2009;9:35.